Spectrofluorimetric determination of gemifloxacin mesylate and linezolid in pharmaceutical formulations: Application of quinone-based fluorophores and enhanced native fluorescence

1. T. L. Lemke, D. A. Williams, V. F. Roche and S. W. Zito, Foye’s Principles of Medicinal Chemistry, 6th ed., Wolters Kluwer, Lippincott Williams & Wilkins, New York 2008.Search in Google Scholar

2. M. J. O’Neil, P. E. Heckelman, C. B. Koch, K. J. Roman, C. M. Kenny and M. R. D’Arecca, The Merck Index, An Encyclopedia of Chemicals, Drugs and Biologicals, 14th ed., Merck Research Laboratories Division of Merck & Co., Inc., Whitehouse Station (NJ) 2006.Search in Google Scholar

3. B. A. Moussa, M. A. Mahrouse, M. A. Hassan and M. G. Fawzy, Stability indicating spectrophotometric and TLC densitometric methods for the determination of gemifloxacin mesylate in tablet form, Anal. Chem. Indian J. 12 (2013) 165-176.Search in Google Scholar

4. C. S. Paim, F. Fuhr, M. Steppe, E. Schapoval and S. Eva, Gemifloxacin mesylate: UV spectrophotometric method for quantitative determination using experimental design for robustness, Quimica Nova. 35 (2012) 193-197; DOI: 10.1590/S0100-40422012000100033.10.1590/S0100-40422012000100033Search in Google Scholar

5. R. El-Bagary, N. F. Abo-Talib and M. B. N. Eldin, Validated stability indicating assay of gemifloxacin by different chromatographic and spectrophotometric methods of analysis, J. Chem. Pharm. Res. 3 (2011) 562-570.Search in Google Scholar

6. S. S. Panda, B. V. V. Ravi Kumar, K. S. Rao, V. R. Kumar and D. Patanaik, Difference spectrophotometric determination of gemifloxacin mesylate in tablet formulation, Asian J. Biochem. Pharm. Res. 1 (2011) 442-447; DOI: 10.1002/bio.2347.10.1002/bio.234722362634Search in Google Scholar

7. K. B. C. Sekhar, D. Madhuri and N. Devanna, Direct and derivative spectrophotometric determination of gemifloxacin mesylate via metal chelate, Acta Cienc. Indica, Ser. Chem. 36 (2010) 165-171.Search in Google Scholar

8. R. Rote Ambadas and S. P. Pingle, Validated UV-spectrophotometric methods for determination of gemifloxacin mesylate in pharmaceutical tablet dosage forms, E-J. Chem. 7 (Suppl. 1) (2010) S344-S348; DOI: 10.1155/2010/346847.10.1155/2010/346847Search in Google Scholar

9. D. Madhuri, K. B. Chandrasekhar, N. Devanna and G. Somasekhar, Direct and derivative spectrophotometric determination of gemifloxacin mesylate in pure form and pharmaceutical preparations using p acceptors, Int. J. Pharm. Sci. Res. 1 (2010) 222-230.Search in Google Scholar

10. Z. Y. Al Shoaibi and A. A. Gouda, Spectrophotometric methods for the determination of gemifloxacin mesylate in pure form and pharmaceutical formulations, Anal. Chem: Indian J. 9 (2010) 129-136.Search in Google Scholar

11. M. V. Krishna and D. G. Sankar, Utility of s and p-acceptors for the spectrophotometric determination of gemifloxacin mesylate in pharmaceutical formulations, E-J. Chem. 5 (2008) 493-498; DOI: 10.1155/2008/801545.10.1155/2008/801545Search in Google Scholar

12. S. E. K. Tekkeli and A. Önal, Spectrofluorimetric methods for the determination of gemifloxacin in tablets and spiked plasma samples, J. Fluoresc. 21 (2011) 1001-1007; DOI: 10.1007/s10895-010-0759-1.10.1007/s10895-010-0759-120981565Search in Google Scholar

13. N. F. Youssef and L. I. Bebawy, Spectrofluorometric methods for the determination of gemifloxacin mesylate and cefamandole nafate in bulk powder and pharmaceutical preparations, Bull. Fac. Pharm. Cairo Univ. 44 (2006) 215-227.Search in Google Scholar

14. A. A. Elbashir, B. A. Saad, S. M. Abdussalam, K. M. M. Al-Azzam and H. Y. Aboul-Enein, Validated stability indicating assay of gemifloxacin and lomefloxacin in tablet formulations by capillary electrophoresis, J. Liq. Chromatogr. Rel. Tech. 31 (2008) 1465-1477; DOI: 10.1080/10826070802039481.10.1080/10826070802039481Search in Google Scholar

15. A. R. Rote and S. P. Pingle, Reversed phase-HPLC and HPTLC methods for determination of gemifloxacin mesylate in human plasma, J. Chromatogr. B 877 (2009) 3719-3723; DOI: 10.1016/ j.jchromb.2009.08.013.10.1016/j.jchromb.2009.08.01319716354Search in Google Scholar

16. D. Nagavalli, G. Abirami and S. K. Kumar, Validated HPLC method for the simultaneous estimation of gemifloxacin mesylate and ambroxol hydrochloride in bulk and tablet dosage form, J. Pharm. Res. 4 (2011) 1701-1703.Search in Google Scholar

17. J. H. Block and J. M. Beals, Wilson and Grisvold's Textbook of Organic Medicinal and Pharmaeutical Chemistry, 11th ed., Wolters Kluwer, Lippincott Williams & Wilkins, New York 2004.Search in Google Scholar

18. M. M. Annapurna, K. S. Kumar and M. V. V. S. G. Reddy, New derivative spectrophotometric methods for the determination of linezolid - an antibacterial drug, J. Chem. Pharm. Res. 4 (2012) 714-718.Search in Google Scholar

19. S. A. Patel, P. U. Patel, N. J. Patel, M. M. Patel and U. V. Bangoriya, High performance thin layer chromatographic method for estimation of linezolid in tablets, Indian J. Pharm. Sci. 69 (2007) 571-574; DOI: 10.4103/0250-474X.36948.10.4103/0250-474X.36948Search in Google Scholar

20. S. Mohapatra, M. M. Annapurna, B. V. V. Ravi Kumar, M. Anwar, M. H. Warsi and S. Akhter, Validated stability indicating RP-HPLC method for the estimation of linezolid in a pharmaceutical dosage form, J. Liq. Chromatogr. Rel. Tech. 34 (2011) 2185-2195; DOI: 10.1080/10826076. 2011.585548.Search in Google Scholar

21. L. Vlase, D. Muntean, M. Cuciureanu, R. Cuciureanu and S. Gocan, High-throughput determination of linezolid in human plasma by liquid chromatography tandem mass spectrometry, J. Liq. Chromatogr. Rel. Tech. 34 (2011) 436-445; DOI: 10.1080/10826076.2011.555677.10.1080/10826076.2011.555677Search in Google Scholar

22. D. Cattaneo, S. Baldelli, F. Conti, V. Cozzi and E. Clementi, Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection, Ther. Drug Monit. 32 (2010) 520-524; DOI: 10.1097/FTD.0b013 e3181d5eeee.Search in Google Scholar

23. N. M. El-Enany, A. Abdelal and F. Belal, Spectrofluorimetric determination of sertraline in dosage forms and human plasma through derivatization with 9-fluorenylmethyl chloroformate, Chem. Central J. 5 (2011) 56-63; DOI: 10.1186/1752-153X-5-56.10.1186/1752-153X-5-56321280921978386Search in Google Scholar

24. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use, Q2 (R1): Validation of Analytical Procedures: Text and Methodology, ICH, Geneva 2005.Search in Google Scholar

25. D. Liming, X. Qingqin and Y. Jianmei, Fluorescence spectroscopy determination of fluoroquinolones by charge-transfer reaction, J. Pharm. Biomed. Anal. 33 (2003) 693-698; DOI: 10.1016/50731-7085(03)00365-0.Search in Google Scholar

26. M. F. Abdel Ghany, A. M. El Kosasy, M. F. Ayad and L. E. Abdel Fattah, Spectrophotometric and spectrofluorimetric determination of gentamicin and tobramycin using 1,4-benzoquinone, Bull. Fac. Pharm. Cairo Univ. 41 (2003) 69-88.Search in Google Scholar

27. S. Sharif, I. U. Khan, T. A. Sheikh, Y. Sharif and M. Ashfaq, Validated stability-indicating HPLC method for analysis of gemifloxacin in tablet formulations, Acta Chromatogr. 41 (2011) 95-107; DOI: 10.1556/AChrom.23.2011.1.6.10.1556/AChrom.23.2011.1.6Search in Google Scholar

28. J. Li and H. Wu, HPLC determination of linezolid plasma concentration, Chin. J. Mod. Appl. Pharm. 27 (2010) 353-355. Search in Google Scholar